Trial Profile

Observational Study of the Effectiveness of Synagis Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus Infection.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Palivizumab (Primary)
Indications Respiratory syncytial virus infections
Focus Therapeutic Use
Acronyms INSPIRA
Sponsors Abbott Laboratories

Most Recent Events

10 Mar 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
10 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
08 Jul 2010 Planned end date changed from 1 Nov 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com